<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38506236</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>Resurgence of human respiratory syncytial virus during COVID-19 pandemic in Southern Brazil.</ArticleTitle><Pagination><StartPage>e29551</StartPage><MedlinePgn>e29551</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.29551</ELocationID><Abstract><AbstractText>Respiratory Syncytial Virus (RSV) is an important cause of respiratory infection in humans. Severe cases are common in children ≤2 years old, immunocompromised individuals, and the elderly. In 2020, RSV infection reduced in Rio Grande do Sul (RS), southern Brazil; however, in 2021 resurgence of RSV was observed. This study analyzed epidemiological and genetic features of RSV infection cases reported in 2021 in RS. Nasopharyngeal samples collected from individuals with respiratory infection negative for SARS-CoV-2, Influenza A and B viruses were assessed for the presence of RSV by real time RT-qPCR. RSV-A and RSV-B genomic sequencing and phylogenetic reconstructions were performed for genotyping and clade characterization. Among 21,035 respiratory samples analyzed, 2,947 were positive for RSV, 947 of which were hospitalized patients. Positive cases were detected year-round, with the highest number in June-July (winter). Children &lt;1 year comprised 56.28% (n = 533) of the hospitalized patients infected with RSV, whereas 14.46% (n = 137) were individuals &gt;60 years. Of a total of 361 deaths, 14.68% (n = 53) were RSV positive, mostly patients &gt;60 years old (73.58%, n = 39). Chronic kidney disease, cardiopathy, Down syndrome and neurological diseases were associated with RSV infection. RSV-A was identified in 58.5% (n = 117/200) of the patients, and RSV-B in 41.5% (n = 83/200). Of 95 RSV genomes recovered from SARI cases, 66 were RSV-A GA.2.3.5 genotype, while 29 were RSV-B GB.5.0.5a genotype. This study provides epidemiological and molecular data on RSV cases in RS during the COVID-19 pandemic and highlights that investigation of different respiratory viruses is essential for decision-making and disease prevention and control measures.</AbstractText><CopyrightInformation>© 2024 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fröhlich</LastName><ForeName>Guilherme C</ForeName><Initials>GC</Initials><Identifier Source="ORCID">0000-0001-8444-5063</Identifier><AffiliationInfo><Affiliation>Laboratório Central de Saúde Pública, Centro Estadual de Vigilância em Saúde da Secretaria de Saúde do Estado do Rio Grande do Sul-LACEN/CEVS/SES-RS, Porto Alegre, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Federal de Ciências da Saúde de Porto Alegre-UFCSPA, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gregianini</LastName><ForeName>Tatiana S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Laboratório Central de Saúde Pública, Centro Estadual de Vigilância em Saúde da Secretaria de Saúde do Estado do Rio Grande do Sul-LACEN/CEVS/SES-RS, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinheiro</LastName><ForeName>Felipe G</ForeName><Initials>FG</Initials><AffiliationInfo><Affiliation>Universidade Federal de Ciências da Saúde de Porto Alegre-UFCSPA, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nascimento</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Universidade Federal de Ciências da Saúde de Porto Alegre-UFCSPA, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cezar</LastName><ForeName>Thiago M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Universidade Federal de Ciências da Saúde de Porto Alegre-UFCSPA, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pscheidt</LastName><ForeName>Veridiane M</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Universidade Federal de Ciências da Saúde de Porto Alegre-UFCSPA, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selayaran</LastName><ForeName>Tainá</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Universidade Federal de Ciências da Saúde de Porto Alegre-UFCSPA, Porto Alegre, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Desenvolvimento Científico e Tecnológico, Centro Estadual de Vigilância em Saúde da Secretaria de Saúde do Estado do Rio Grande do Sul-CDCT/CEVS/SES-RS, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Letícia G</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Centro Estadual de Vigilância em Saúde da Secretaria de Saúde do Estado do Rio Grande do Sul-CEVS/SES-RS, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomes</LastName><ForeName>Marcelo Ferreira da Costa</ForeName><Initials>MFDC</Initials><AffiliationInfo><Affiliation>Programa de Computação Científica, Instituto Oswaldo Cruz-PROCC/FIOCRUZ-RJ, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salvato</LastName><ForeName>Richard S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Centro de Desenvolvimento Científico e Tecnológico, Centro Estadual de Vigilância em Saúde da Secretaria de Saúde do Estado do Rio Grande do Sul-CDCT/CEVS/SES-RS, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Elisa C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Laboratório Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais - LVRE/FIOCRUZ-RJ, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guimarães-Ribeiro</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Laboratório Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais - LVRE/FIOCRUZ-RJ, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scalioni</LastName><ForeName>Letícia de Paula</ForeName><Initials>LP</Initials><AffiliationInfo><Affiliation>Laboratório Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais - LVRE/FIOCRUZ-RJ, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siqueira</LastName><ForeName>Marilda M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Laboratório Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais - LVRE/FIOCRUZ-RJ, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Resende</LastName><ForeName>Paola C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Laboratório Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais - LVRE/FIOCRUZ-RJ, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veiga</LastName><ForeName>Ana B G</ForeName><Initials>ABG</Initials><Identifier Source="ORCID">0000-0003-1462-5506</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Ciências da Saúde de Porto Alegre-UFCSPA, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>LACEN-RS Team</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul</Agency><Country /></Grant><Grant><Agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018113" MajorTopicYN="Y">Respiratory Syncytial Virus, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018357" MajorTopicYN="Y">Respiratory Syncytial Virus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">molecular epidemiology</Keyword><Keyword MajorTopicYN="N">respiratory syncytial virus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>21</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>20</Day><Hour>12</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38506236</ArticleId><ArticleId IdType="doi">10.1002/jmv.29551</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Law BJ, Carbonell-Estrany X, Simoes EAF. An update on respiratory syncytial virus epidemiology: a developed country perspective. Respir Med. 2002;96:S1-S7.</Citation></Reference><Reference><Citation>Boattini M, Almeida A, Christaki E, et al. Severity of RSV infection in Southern European elderly patients during two consecutive winter seasons (2017-2018). J Med Virol. 2021;93:5152-5157.</Citation></Reference><Reference><Citation>International Committee on Taxonomy of Viruses. Family: PneumovidaePneumoviridae; Genus: Orthopneumovirus. 2022. Accessed December 11, 2021. https://ictv.global/report/chapter/pneumoviridae/pneumoviridae/orthopneumovirus/</Citation></Reference><Reference><Citation>Muñoz-Escalante JC, Comas-García A, Bernal-Silva S, Robles-Espinoza CD, Gómez-Leal G, Noyola DE. Respiratory syncytial virus A genotype classification based on systematic intergenotypic and intragenotypic sequence analysis. Sci Rep. 2019;9:20097.</Citation></Reference><Reference><Citation>Goya S, Galiano M, Nauwelaers I, et al. Toward unified molecular surveillance of RSV: a proposal for genotype definition. Influenza Other Respir Viruses. 2020;14:274-285.</Citation></Reference><Reference><Citation>Eshaghi A, Duvvuri VR, Lai R, et al. Genetic variability of human respiratory syncytial virus A strains circulating in Ontario: a novel genotype with a 72 nucleotide G gene duplication. PLoS One. 2012;7:e32807.</Citation></Reference><Reference><Citation>Trento A, Galiano M, Videla C, et al. Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides. J Gen Virol. 2003;84:3115-3120.</Citation></Reference><Reference><Citation>Hirano E, Kobayashi M, Tsukagoshi H, et al. Molecular evolution of human respiratory syncytial virus attachment glycoprotein (G) gene of new genotype ON1 and ancestor NA1. Infect Genet Evol. 2014;28:183-191.</Citation></Reference><Reference><Citation>Midulla F, Nenna R, Scagnolari C, et al. How respiratory syncytial virus genotypes influence the clinical course in infants hospitalized for bronchiolitis. J Infect Dis. 2019;219:526-534.</Citation></Reference><Reference><Citation>Hornsleth A, Klug B, Nir M, et al. Severity of respiratory syncytial virus disease related to type and genotype of virus and to cytokine values in nasopharyngeal secretions. Pediatr Infect Dis J. 1998;17:1114-1121.</Citation></Reference><Reference><Citation>Anderson LJ, Peret TC, Piedra PA. RSV strains and disease severity. J Infect Dis. 2019;219:514-516.</Citation></Reference><Reference><Citation>Silva DGBP, Almeida FJ, Arnoni MV, et al. First report of two consecutive respiratory syncytial virus outbreaks by the novel genotypes ON-1 and NA-2 in a neonatal intensive care unit. J Pediatr. 2020;96:233-239.</Citation></Reference><Reference><Citation>Vianna L, Siqueira MM, Resende PC, et al. Seasonality, molecular epidemiology, and virulence of respiratory syncytial virus (RSV): a perspective into the Brazilian influenza surveillance program. PLoS One. 2021;15:5.</Citation></Reference><Reference><Citation>Li Y, Hodgson D, Wang X, Atkins KE, Feikin DR, Nair H. Respiratory syncytial virus seasonality and prevention strategy planning for passive immunisation of infants in low-income and middle-income countries: a modelling study. Lancet Infect Dis. 2021;21:1303-1312.</Citation></Reference><Reference><Citation>Zhao X, Liu E, Chen FP, Sullender WM. In vitro and in vivo fitness of respiratory syncytial virus monoclonal antibody escape mutants. J Virol. 2006;80:11651-11657.</Citation></Reference><Reference><Citation>Shmueli E, Goldberg O, Mei-Zahav M, et al. Risk factors for respiratory syncytial virus bronchiolitis hospitalizations in children with chronic diseases. Pediatr Pulmonol. 2021;56:2204-2211.</Citation></Reference><Reference><Citation>Secretaria de Atenção à Saúde. Ministério da Saúde. Portaria n° 522, de 13 de maio de; 2013. Accessed September 15, 2023. https://bvsms.saude.gov.br/bvs/saudelegis/sas/2013/prt0522_13_05_2013.html/</Citation></Reference><Reference><Citation>Adams O, Bonzel L, Kovacevic A, Mayatepek E, Hoehn T, Vogel M. Palivizumab-resistant human respiratory syncytial virus infection in infancy. Clin Infect Dis. 2010;51:185-188.</Citation></Reference><Reference><Citation>Malik S, Ahmad T, Muhammad K, Waheed Y. Respiratory syncytial virus infection: treatments and clinical management. Vaccines. 2023;11:491.</Citation></Reference><Reference><Citation>U.S. Food and Drug Administration. Respiratory Syncytial Virus (RSV)-There are FDA-approved vaccines and monoclonal antibodies for RSV now available. 2023. Accessed January 20, 2024. https://www.fda.gov/consumers/covid-19-flu-and-rsv/respiratory-syncytial-virus-rsv#:~:text=There%20are%20two%20FDA%2Dapproved,and%20older%20%2D%20Abrysvo%20and%20Arexvy</Citation></Reference><Reference><Citation>World Health Organization. WHO Strategy for the Global Respiratory Syncytial Virus Surveillance based on Influenza Surveillance in 2019. 2019. https://cdn.who.int/media/docs/default-source/influenza/rsv-surveillance/who-rsv-surveillance-strategy-phase-26mar2021.-final.pdf?sfvrsn=d8b1c36a_9/</Citation></Reference><Reference><Citation>Freitas ARR, Donalisio MR. Respiratory syncytial virus seasonality in Brazil: implications for the immunisation policy for at-risk populations. Mem Inst Oswaldo Cruz. 2016;111:294-301.</Citation></Reference><Reference><Citation>Gregianini TS, Seadi CF, Menegolla I, et al. Human metapneumovirus in Southern Brazil. Rev Soc Bras Med Trop. 2018;51:30-38.</Citation></Reference><Reference><Citation>Centro Estadual de Vigilância em Saúde. Secretaria Estadual de Saúde do Rio Grande do Sul-Boletim epidemiológico de vírus respiratórios de interesse à saúde pública até Semana Epidemiológica 43 de 2022. 2022. Accessed September 07, 2023. https://coronavirus.rs.gov.br/upload/arquivos/202211/03152619-boletim-epidemiologico-virus-resiratorios-se-43-2022.pdf/</Citation></Reference><Reference><Citation>Billard M-N, Van de Ven PM, Baraldi B, Kragten-Tabatabaie L, Bont LJ, Wildenbeest JG. International changes in respiratory syncytial virus (RSV) epidemiology during the COVID-19 pandemic: association with school closures. Influenza Other Respir Viruses. 2022;16:926-936.</Citation></Reference><Reference><Citation>Estado do Rio Grande do Sul. Relatório: Subcomissão de organização das macrorregiões de saúde-Assembleia Legislativa/Comissão de Saúde e Meio Ambiente 2011. Accessed July 17, 2023. https://www.al.rs.gov.br/download/SubMacrorregioes_saude/RFMacrorr_Sa%C3%BAde.pdf/</Citation></Reference><Reference><Citation>Ministério da Saúde. Gripe (Influenza) 2023. 2023. Accessed December 15, 2021. https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/g/gripe-influenza/</Citation></Reference><Reference><Citation>Fry AM, Chittaganpitch M, Baggett HC, et al. The burden of hospitalized lower respiratory tract infection due to respiratory syncytial virus in rural Thailand. PLoS One. 2010;5:e15098.</Citation></Reference><Reference><Citation>Williams T, Jackson S, Barr I, et al. Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019-2020. Influenza Other Respir Viruses. 2023;17:e13073.</Citation></Reference><Reference><Citation>Dezordi FZ, Neto AMS, Campos TL, et al. ViralFlow: a versatile automated workflow for SARS-CoV-2 genome assembly, lineage assignment, mutations and intrahost variant detection. Viruses. 2022;14:217.</Citation></Reference><Reference><Citation>Khare S, Gurry C, Freitas L, et al. GISAID's role in pandemic response. China CDC Weekly. 2021;3(49):1049-1051. doi:10.46234/ccdcw2021.255</Citation></Reference><Reference><Citation>Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215(3):403-410.</Citation></Reference><Reference><Citation>Katoh K, Standley DM. MAAFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013;4:80-772.</Citation></Reference><Reference><Citation>Nguyen L-T, Schmidt HA, von Haeseler A, Minh BQ. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol. 2014;32:268-274.</Citation></Reference><Reference><Citation>Ramaekers K, Rector A, Cuypers L, Lemey P, Keyaerts E, Van Ranst M. Towards a unified classification for human respiratory syncytial virus genotypes. Virus Evol. 2020;6:2.</Citation></Reference><Reference><Citation>Ratolojanahary R, Houé Ngouna R, Medjaher K, Junca-Bourié J, Dauriac F, Sebilo M. Model selection to improve multiple imputation for handling high rate missingness in a water quality dataset. Expert Syst Appl. 2019;131:299-307.</Citation></Reference><Reference><Citation>Nguyen CD, Carlin JB, Lee KJ. Model checking in multiple imputation: an overview and case study. Emerg Themes Epidemiol. 2017;14:8.</Citation></Reference><Reference><Citation>R Foundation for Statistical Computing. R Core Team. R: A language and Environment for Statistical Computing; 2021. Accessed November 10, 2023. https://www.R-project.org/</Citation></Reference><Reference><Citation>Heymans M. Miceafter: Data and Statistical Analyses after Multiple Imputation (R package version 0.5.0); 2022. Accessed November 10, 2023. https://mwheymans.github.io/miceafter/</Citation></Reference><Reference><Citation>Yasui Y, Yamaji Y, Sawada A, Ito T, Nakayama T. Cell fusion assay by expression of respiratory syncytial virus (RSV) fusion protein to analyze the mutation of palivizumab-resistant strains. J Virol Methods. 2016;231:48-55.</Citation></Reference><Reference><Citation>Lucion MF, Del Valle Juárez M, Pejito MN, et al. Impact of COVID-19 on the circulation of respiratory viruses in a children's hospital: an expected absence. Arch Argent Pediatr. 2022;120:99-105.</Citation></Reference><Reference><Citation>Castagno E, Raffaldi I, Del Monte F, Garazzino S, Bondone C. New epidemiological trends of respiratory syncytial virus bronchiolitis during COVID-19 pandemic. World J Pediatr. 2023;19:502-504.</Citation></Reference><Reference><Citation>Sabeena S, Ravishankar N, Robin S, Pillai S. The impact of coronavirus disease 2019 pandemic on bronchiolitis (lower respiratory tract infection) due to respiratory syncytial virus: a systematic review and meta-analysis. Indian J Public Health. 2023;67:284-291.</Citation></Reference><Reference><Citation>Britton PN, Hu N, Saravanos G, et al. COVID-19 public health measures and respiratory syncytial virus. Lancet Child Adolesc Health. 2020;4:e42-e43.</Citation></Reference><Reference><Citation>Tempia S, Walaza S, Bhiman JN, et al. Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Euro Surveill. 2021;26:200-1600.</Citation></Reference><Reference><Citation>Ministério da Saúde. Informe Epidemiológico de Influenza (Monitoramento até a Semana Epidemiológica 52 de 2019). 2020. Accessed September 07, 2023. https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/g/gripe-influenza/arquivos/informe-epidemiologico-sobre-influenza-2019.pdf/view/</Citation></Reference><Reference><Citation>Bloom-Feshbach K, Alonso WJ, Charu V, et al. Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review. PLoS One. 2013;8:e54445.</Citation></Reference><Reference><Citation>Staadegaard L, Caini S, Wangchuk S, et al. Defining the seasonality of respiratory syncytial virus around the world: national and subnational surveillance data from 12 countries. Influenza Other Respir Viruses. 2021;15:732-741.</Citation></Reference><Reference><Citation>Shi T, Balsells E, Wastnedge E, et al. Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: systematic review and meta-analysis. J Glob Health. 2015;5:020416.</Citation></Reference><Reference><Citation>Ackerson B, Tseng HF, Sy LS, et al. Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults. Clin Infect Dis. 2019;69:197-203.</Citation></Reference><Reference><Citation>Cong B, Dighero I, Zhang T, Chung A, Nair H, Li Y. Understanding the age spectrum of respiratory syncytial virus associated hospitalisation and mortality burden based on statistical modelling methods: a systematic analysis. BMC Med. 2023;21:224.</Citation></Reference><Reference><Citation>Leung NHL. Transmissibility and transmission of respiratory viruses. Nat Rev Microbiol. 2021;19:528-545.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>